Medicare’s 2026 drug price negotiations under the Inflation Reduction Act aim to lower the cost of expensive medications, ...

Eliquis and Xarelto, two blood-thinning medications that are already among Medicare's costliest, have seen their list prices more than double since entering the market, finds a new report by Patients ...

Negotiations are expected to continue in future cycles as part of President Donald Trump's "aggressive push for lower prices.

Medicare, the health insurance program for people over 65 years old, said it will start negotiating prices on 10 drugs, part of its mandate under the Inflation Reduction Act to lower prescription ...

For many of us, Thursday was Health-Policy-Wonk Festivus. The Centers for Medicare & Medicaid Services released the Maximum Fair Prices (MFPs) for the first 10 drugs subject to negotiation under the ...

CMS released its highly anticipated list of 10 drugs subject to Medicare price negotiations Tuesday, which includes popular blood clot prevention drugs Eliquis and Xarelto and diabetes drugs Jardiance ...

The federal government’s newly announced savings on 15 expensive prescriptions include the popular Ozempic family of ...

Millions of Americans on Medicare are treating blood clots, cancer, heart disease and diabetes with 10 expensive and widely prescribed medications including Xarelto, Eliquis and Jardiance. Now, the 10 ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicaid recipients will pay less for 15 prescription drugs, including popular weight loss medications Ozempic and Wegovy, asthma ...

The Biden administration is taking a victory lap after federal officials inked deals with drug companies to lower the price for 10 of Medicare’s most popular and costliest drugs. White House officials ...

The first 10 prescription drugs the federal government will negotiate under a new federal law were revealed Tuesday, launching a process that could deliver drug discounts by 2026. The batch of 10 ...

LONDON (Reuters) - Bayer AG has launched its new anticoagulant pill Xarelto in Britain and Germany, pricing the product on a par with Sanofi-Aventis's Lovenox injection, the company said on Thursday.